---
title: "Biggest stock movers Thursday: FIZZ, CANF, and more"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291525078.md"
description: "Stock futures pointed lower on Thursday ahead of the June jobs report and Independence Day. National Beverage (FIZZ) rose 6% after declaring a $3.25 special dividend, citing strong FY2026 results. Can-Fite BioPharma (CANF) fell 12% despite positive Phase 2a data for Namodenoson in pancreatic cancer. Embraer (EMBJ) dropped 5% after acquiring full ownership of its EZ Air Interior joint venture with Safran Cabin."
datetime: "2026-07-02T09:30:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291525078.md)
  - [en](https://longbridge.com/en/news/291525078.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291525078.md)
generator: "portal-rs"
---

# Biggest stock movers Thursday: FIZZ, CANF, and more


### Related Stocks

- [EMBJ.US](https://longbridge.com/en/quote/EMBJ.US.md)
- [FIZZ.US](https://longbridge.com/en/quote/FIZZ.US.md)
- [CANF.US](https://longbridge.com/en/quote/CANF.US.md)

## Related News & Research

- [Can-Fite plans Phase IIb trial of namodenoson plus gemcitabine in advanced pancreatic cancer](https://longbridge.com/en/news/296095129.md)
- [Embraer Phenom 300EV wins ANAC, FAA and EASA certification](https://longbridge.com/en/news/296912254.md)
- [Alpha Tau completes enrollment in 48-patient IMPACT pancreatic cancer Alpha DaRT pilot study](https://longbridge.com/en/news/297513505.md)
- [Propanc Biopharma Announces Positive Preclinical Data For PRP In Pancreatic Cancer, Stock Soars](https://longbridge.com/en/news/297195775.md)
- [Emmaus Life Sciences Announces Agreement for Evaluation of L-glutamine for Pancreatic Cancer | EMMA Stock News](https://longbridge.com/en/news/297525880.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**